Integrative precision oncology in neuroblastoma: multi-omics biomarkers, molecular targets, and immunotherapeutic strategies.

Singh A, Goel N, Mehndiratta S, Chaudhry A, Kaur M, Swain SK, Prabhakar P, Misra A, Rishi B

DOI: 10.3389/fonc.2026.1879586
Published: 2026
Container: Frontiers in oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1879586,
  title = {Integrative precision oncology in neuroblastoma: multi-omics biomarkers, molecular targets, and immunotherapeutic strategies.},
  author = {Singh A and Goel N and Mehndiratta S and Chaudhry A and Kaur M and Swain SK and Prabhakar P and Misra A and Rishi B},
  year = {2026},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2026.1879586},
  url = {https://doi.org/10.3389/fonc.2026.1879586}
}

RIS

TY  - JOUR
TI  - Integrative precision oncology in neuroblastoma: multi-omics biomarkers, molecular targets, and immunotherapeutic strategies.
AU  - Singh A
AU  - Goel N
AU  - Mehndiratta S
AU  - Chaudhry A
AU  - Kaur M
AU  - Swain SK
AU  - Prabhakar P
AU  - Misra A
AU  - Rishi B
PY  - 2026
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2026.1879586
UR  - https://doi.org/10.3389/fonc.2026.1879586
ER  -

APA

A, S., N, G., S, M., A, C., M, K., SK, S., P, P., A, M., & B, R. (2026). Integrative precision oncology in neuroblastoma: multi-omics biomarkers, molecular targets, and immunotherapeutic strategies.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1879586

Source records

pubmed · retrieved 2026-09-25T13:09:27.326Z